tiprankstipranks
Trending News
More News >
Scinai Immunotherapeutics (SCNI)
NASDAQ:SCNI
US Market
Advertisement

Scinai Immunotherapeutics (SCNI) Income Statement

Compare
331 Followers

Scinai Immunotherapeutics Income Statement

Last quarter (Q2 2025), Scinai Immunotherapeutics's total revenue was $386.50K, an increase of 36.09% from the same quarter last year. In Q2, Scinai Immunotherapeutics's net income was $-2.07M. See Scinai Immunotherapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 658.00K$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ -580.00K$ -512.67K$ -559.80K$ -747.65K$ -708.92K
Operating Expenses
$ 8.06M$ 9.71M$ 11.06M$ 10.86M$ -2.28M
Depreciation and Amortization
$ 1.65M$ 514.00K$ 562.00K$ 471.00K$ 468.56K
EBITDA
$ 7.87M$ -9.19M$ -10.50M$ -10.39M$ 2.75M
Operating Income
$ -8.64M$ -9.71M$ -11.06M$ -10.87M$ 2.28M
Other Income/Expenses
$ 13.43M$ 3.21M$ 5.26M$ 2.67M$ -3.67M
Pretax Income
$ 4.80M$ -6.50M$ -5.80M$ -8.21M$ -1.39M
Net Income
$ 4.80M$ -6.50M$ -5.80M$ -8.21M$ -1.39M
Per Share Metrics
Basic EPS
$ 6.00$ -16.80$ -30.80$ -87.60$ -12.40
Diluted EPS
$ 6.00$ -16.80$ -30.80$ -80.00$ -12.40
Weighted Average Shares Outstanding
806.37K 390.66K 188.52K 102.57K 110.81K
Weighted Average Shares Outstanding (Diluted)
806.37K 390.66K 188.52K 141.14K 110.81K
Currency in USD

Scinai Immunotherapeutics Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis